Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$897K Hold
2,551
0.43% 31
2025
Q4
$835K Hold
2,551
0.4% 33
2025
Q3
$720K Hold
2,551
0.36% 37
2025
Q2
$712K Buy
2,551
+1,351
+113% +$383K 0.38% 37
2025
Q1
$374K Hold
1,200
0.22% 55
2024
Q4
$313K Hold
1,200
0.19% 62
2024
Q3
$387K Hold
1,200
0.24% 50
2024
Q2
$375K Hold
1,200
0.25% 50
2024
Q1
$341K Hold
1,200
0.23% 57
2023
Q4
$346K Hold
1,200
0.24% 55
2023
Q3
$323K Hold
1,200
0.24% 54
2023
Q2
$266K Hold
1,200
0.19% 68
2023
Q1
$290K Hold
1,200
0.21% 62
2022
Q4
$315K Hold
1,200
0.24% 58
2022
Q3
$270K Hold
1,200
0.3% 47
2022
Q2
$292K Hold
1,200
0.31% 45
2022
Q1
$290K Hold
1,200
0.27% 54
2021
Q4
$270K Hold
1,200
0.23% 65
2021
Q3
$255K Hold
1,200
0.23% 60
2021
Q2
$293K Hold
1,200
0.27% 56
2021
Q1
$299K Hold
1,200
0.3% 52
2020
Q4
$276K Buy
+1,200
New +$277K 0.22% 61

Other funds holding AMGN

ADE LLC's AMGN Position: Q1 2026 in Review

ADE LLC held its Amgen (AMGN) position steady in Q1 2026 at 2,551 shares worth $897K. The position accounts for 0.43% of the portfolio, ranked #31.

ADE LLC first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • ADE LLC held 2,551 shares of Amgen worth $897K as of Q1 2026.
  • ADE LLC left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.43% of ADE LLC's portfolio in Q1 2026, its #31 holding.
  • ADE LLC first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ADE LLC's 13F filing for Q1 2026, filed 14 May 2026.